» Authors » Natasa Draca

Natasa Draca

Explore the profile of Natasa Draca including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 209
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Draca N, Oreskovic E, Lazic R, Vukojevic M, Bertetic A, Vukojevic N
Medicina (Kaunas) . 2023 Dec; 59(12). PMID: 38138261
: This study reports a case of a 62-year-old patient experiencing a significant decline in vision over the past three months. The initial best-corrected visual acuity (BCVA) of 20/20 in...
2.
Sharma A, Wu L, Bloom S, Stanga P, Sallam A, Villa-Pineros J, et al.
Ophthalmic Surg Lasers Imaging Retina . 2023 Jul; 54(7):380-383. PMID: 37463003
No abstract available.
3.
Draca N, Cerovski B, Lazic R, Kovacevic D, Gabric K, Gabric I
Case Rep Ophthalmol . 2020 Oct; 11(2):395-401. PMID: 32999667
We describe a case of optical coherence tomography angiography (OCTA) changes in the foveal avascular zone (FAZ) in a patient that had suffered Berlin's edema after a whiplash neck injury....
4.
Lazic R, Draca N, Cerovic V, Katic D, Mladenovski S, Gabric N
Ophthalmic Surg Lasers Imaging Retina . 2018 Sep; 49(9):e89-e92. PMID: 30222825
A patient presented with a large chronic macular hole (MH) of 700 μm. Best-corrected visual acuity (BCVA) was 20/200. Since the MHs edges were attached and stiff, an autologous neurosensory...
5.
Bohac M, Anticic M, Draca N, Kozomara B, Dekaris I, Gabric N, et al.
Semin Ophthalmol . 2016 Aug; 32(6):725-733. PMID: 27487324
Purpose: To compare refractive stability, endothelial cell count (ECC), incidence of complications, and patients' satisfaction between a rigid Verisyse (group I, n = 198) and foldable Veriflex (group II, n...
6.
Dekaris I, Gabric N, Draca N, Pauk-Gulic M, Milicic N
Graefes Arch Clin Exp Ophthalmol . 2014 Nov; 253(2):287-94. PMID: 25398659
Purpose: To evaluate the effect of combined subconjunctival and topical bevacizumab treatment on corneal graft survival rate in high-risk eyes. Methods: Prospective, consecutive, interventional case series. Fifty eyes of 50...
7.
Dumic-cule I, Brkljacic J, Rogic D, Bordukalo Niksic T, Tikvica Luetic A, Draca N, et al.
Int Orthop . 2014 Jul; 38(9):1979-85. PMID: 25030962
Purpose: Bone morphogenetic protein (BMP)-2 and -7 are used in patients with long-bone fractures, nonunions and spinal fusions. It is unknown whether their potential systemic bioavailability following local bone administration...
8.
Lazic R, Lukic M, Boras I, Draca N, Vlasic M, Gabric N, et al.
Retina . 2013 Aug; 34(4):719-24. PMID: 23975006
Purpose: To investigate the efficiency of intravitreal dexamethasone implant in patients with chronic diabetic macular edema nonresponsive to three consecutive monthly intravitreal injections of anti-vascular endothelial growth factor administered previously....
9.
Dekaris I, Gabric N, Pauk M, Draca N
Acta Ophthalmol . 2013 Feb; 92(3):282-5. PMID: 23388035
Purpose: To describe a modified graft-over-host (MGOH) surgical technique which was used to prevent serious complications in cases of positive vitreal pressure during penetrating keratoplasty (PKP) and to compare the...
10.
Draca N, Lazic R, Simic P, Dumic-cule I, Tikvica Luetic A, Gabric N
Med Hypotheses . 2013 Jan; 80(4):431-5. PMID: 23357670
Patients with chronic kidney disease (CKD) experience co-morbid illnesses, including cardiovascular disease and retinopathy. Sevelamer hydrochloride (Renagel®); a non-calcium phosphate binder reduces coronary artery and aortic calcification as compared to...